|
293 Companies |
|
491 Products |
|
491 Products |
|
198 Mechanisms of Action |
|
26 Trials |
|
7806 News |
|
| «12...145146147148149150151152153154155156157» |
- Trial completion: Coccinelle: Low Grade Inflammation in Type 1 Diabetes Children (clinicaltrials.gov) - Oct 23, 2011
P=N/A, N=80, Completed, Sponsor: University Hospital, Bordeaux
Recruiting --> Completed
- New P2 trial: Honey in Chronic Immune Thrombocytopenia (clinicaltrials.gov) - Oct 20, 2011
P2, N=30, Not yet recruiting, Sponsor: mamdouh abdulmaksoud abdulrhman
- | Kesimpta (ofatumumab subcutaneous) / Novartis, Genmab
New P2 trial: Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis (clinicaltrials.gov) - Oct 20, 2011
P2, N=232, Active, not recruiting, Sponsor: GlaxoSmithKline
- | Kevzara (sarilumab) / Asahi Kasei, Regeneron, Sanofi
Trial completion: Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients (clinicaltrials.gov) - Oct 20, 2011
P1, N=32, Completed, Sponsor: Sanofi
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| New P4 trial: MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia (clinicaltrials.gov) - Oct 19, 2011
P4, N=180, Completed, Sponsor: Biogen Idec
- glatiramer acetate / Generic mfg.
New P4 trial: Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities (clinicaltrials.gov) - Oct 18, 2011
P4, N=10, Completed, Sponsor: University of Southern California
- | prednisone / Generic mfg.
Enrollment change: Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy (clinicaltrials.gov) - Oct 18, 2011
P3, N=150, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed N=200 --> 150
- | MIKA Diclofenac Spray Gel (diclofenac spraygel) / Nogra Pharma
New P4 trial: Adjuvant Treatment of Graves (clinicaltrials.gov) - Oct 18, 2011
P4, N=65, Active, not recruiting, Sponsor: Mikael Lantz
- | New P4 trial: Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate (clinicaltrials.gov) - Oct 17, 2011
P4, N=40, Completed, Sponsor: Brown, Theodore R., M.D., MPH
- Enrollment closed: Use of Two Deep Brain Stimulation (DBS) Electrodes to Treat Post-Traumatic Tremor (clinicaltrials.gov) - Oct 17, 2011
P=N/A, N=20, Active, not recruiting, Sponsor: University of Florida
N=200 --> 150 Recruiting --> Active, not recruiting
- | DegludecPlus (insulin degludec/insulin aspart) / Novo Nordisk
New P1 trial: A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes (clinicaltrials.gov) - Oct 17, 2011
P1, N=32, Completed, Sponsor: Novo Nordisk
- New P1/2 trial, Stroma: Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis (clinicaltrials.gov) - Oct 16, 2011
P1/2, N=10, Not yet recruiting, Sponsor: Ageless Regenerative Institute
- ||||| New P4 trial: Effect of CSII and CGM on Progression of Late Diabetic Complications (clinicaltrials.gov) - Oct 16, 2011
P4, N=80, Recruiting, Sponsor: Steen Andersen
- |||||||||| insulin peglispro (LY2605541) / Eli Lilly
New P3 trial: IMAGINE 3: A Study in Participants With Type I Diabetes Mellitus (clinicaltrials.gov) - Oct 16, 2011
P3, N=1113, Completed, Sponsor: Eli Lilly and Company
- ||||||| Actemra IV (tocilizumab) / Roche, JW Pharma
Trial completion: An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy. (clinicaltrials.gov) - Oct 16, 2011
P3, N=1697, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||| New P2 trial: Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis (clinicaltrials.gov) - Oct 13, 2011
P2, N=201, Completed, Sponsor: Tranzyme, Inc.
- New P2 trial: Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II (clinicaltrials.gov) - Oct 12, 2011
P2, N=18, Terminated, Sponsor: Louisiana State University Health Sciences Center in New Orleans
- ||| Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Trial completion: REMission: Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) (clinicaltrials.gov) - Oct 12, 2011
P=N/A, N=4485, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | mycophenolate mofetil / Generic mfg., azathioprine / Generic mfg.
Trial completion: MAINTAIN: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis. (clinicaltrials.gov) - Oct 12, 2011
P3, N=105, Completed, Sponsor: Frédéric A. Houssiau, MD, PhD
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | phenytoin / Generic mfg.
New P2 trial: Neuroprotection With Phenytoin in Optic Neuritis (clinicaltrials.gov) - Oct 11, 2011
P2, N=90, Recruiting, Sponsor: University College, London
- hydrocortisone / Generic mfg.
New P2 trial: PHYSCA: Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency (clinicaltrials.gov) - Oct 11, 2011
P2, N=12, Completed, Sponsor: Bruno Allolio
- |||||||||| Cimzia (certolizumab pegol) / Astellas, UCB
Biomarker, New P3 trial: Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis (clinicaltrials.gov) - Oct 11, 2011
P3, N=316, Active, not recruiting, Sponsor: Astellas Pharma Inc
- | toreforant (JNJ-38518168) / J&J
New P1 trial: A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants (clinicaltrials.gov) - Oct 11, 2011
P1, N=20, Completed, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- |||| fosdagrocorat (PF-04171327) / Pfizer
Enrollment open, P2 data: Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis (clinicaltrials.gov) - Oct 10, 2011
P2, N=315, Recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
Trial completion: Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study (clinicaltrials.gov) - Oct 10, 2011
P4, N=100, Completed, Sponsor: Tuen Mun Hospital
Not yet recruiting --> Recruiting Recruiting --> Completed
- Actemra IV (tocilizumab) / Roche, JW Pharma
New P2 trial: Tocilizumab for Patients With Giant Cell Arteritis (clinicaltrials.gov) - Oct 10, 2011
P2, N=27, Recruiting, Sponsor: University Hospital Inselspital, Berne
- ||| Olumiant (baricitinib) / Incyte, Eli Lilly
Enrollment closed: A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy (clinicaltrials.gov) - Oct 10, 2011
P2, N=270, Active, not recruiting, Sponsor: Eli Lilly and Company
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Humalog pen (insulin lispro) / Eli Lilly
Trial completion: Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog (clinicaltrials.gov) - Oct 10, 2011
P1, N=13, Completed, Sponsor: Biodel
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||| tacrolimus intravenous / Generic mfg.
Enrollment change: Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate (clinicaltrials.gov) - Oct 6, 2011
P4, N=78, Completed, Sponsor: Astellas Pharma Inc
Recruiting --> Completed N=47 --> 78
- | tacrolimus intravenous / Generic mfg.
Trial completion: A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients (clinicaltrials.gov) - Oct 6, 2011
P2, N=40, Completed, Sponsor: Astellas Pharma Inc
N=47 --> 78 Recruiting --> Completed
- | Diamyd (recombinant 65 kDa isoform of human glutamic acid decarboxylase) / Diamyd Medical
Trial termination: A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU) (clinicaltrials.gov) - Oct 6, 2011
P3, N=334, Terminated, Sponsor: Diamyd Therapeutics AB
Recruiting --> Completed Active, not recruiting --> Terminated; The primary endpoint at 15 months was not met.
- | Kinaction (masitinib) / AB Science
New P2 trial: Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis (clinicaltrials.gov) - Oct 5, 2011
P2, N=35, Completed, Sponsor: AB Science
- New P2 trial: Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE (clinicaltrials.gov) - Oct 5, 2011
P2, N=20, Recruiting, Sponsor: University at Buffalo Neurosurgery
- | Epratucyn (epratuzumab) / Gilead
New P1/2 trial: Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) (clinicaltrials.gov) - Oct 5, 2011
P1/2, N=20, Completed, Sponsor: UCB, Inc.
- ||| Rebif (human IFN-β-1a) / EMD Serono
Trial completion, Adherence: Safety, Tolerability and Adherence With Rebif® New Formulation in Real Life Settings (STAR) (clinicaltrials.gov) - Oct 5, 2011
P=N/A, N=256, Completed, Sponsor: Merck KGaA
Active, not recruiting --> Terminated; The primary endpoint at 15 months was not met. Active, not recruiting --> Completed
- | Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
Clinical: RUMBA: A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate (clinicaltrials.gov) - Oct 5, 2011
P2, N=42, Completed, Sponsor: Genentech
Active, not recruiting --> Completed Active, not recruiting --> Completed
- New P1/2 trial: T Cell Vaccination in Patients With Progressive Multiple Sclerosis (clinicaltrials.gov) - Oct 4, 2011
P1/2, N=30, Completed, Sponsor: Hadassah Medical Organization
- |||| tacrolimus intravenous / Generic mfg.
Trial completion: Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate (clinicaltrials.gov) - Oct 4, 2011
P4, N=78, Completed, Sponsor: Astellas Pharma Inc
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: Assessment of an Alternative Model of Follow-up of Children and Adolescents With Type 1 Diabetes (clinicaltrials.gov) - Oct 4, 2011
P=N/A, N=82, Completed, Sponsor: University of Calgary
Recruiting --> Completed N=110 --> 82
- | Tavalisse (fostamatinib) / Rigel
Trial completion, Combination therapy: Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy Subjects (clinicaltrials.gov) - Oct 4, 2011
P1, N=21, Completed, Sponsor: AstraZeneca
N=110 --> 82 Active, not recruiting --> Completed
- Trial completion: Assessment of an Alternative Model of Follow-up of Children and Adolescents With Type 1 Diabetes (clinicaltrials.gov) - Oct 4, 2011
P=N/A, N=82, Completed, Sponsor: University of Calgary
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || Enrollment change, HEOR: Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone) (clinicaltrials.gov) - Oct 3, 2011
P=N/A, N=2728, Completed, Sponsor: Merck KGaA
Active, not recruiting --> Completed N=8000 --> 2728
- ||| New P3 trial: SPARROW: Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis (clinicaltrials.gov) - Oct 3, 2011
P3, N=216, Suspended, Sponsor: Nordic Pharma SAS
- ||| Trial completion, HEOR: Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone) (clinicaltrials.gov) - Oct 3, 2011
P=N/A, N=2728, Completed, Sponsor: Merck KGaA
N=8000 --> 2728 Active, not recruiting --> Completed
- || New P3 trial: Effectiveness of Water Exercises on Isokinetic Muscle Strength (clinicaltrials.gov) - Oct 2, 2011
P3, N=100, Completed, Sponsor: Federal University of São Paulo
- | Savella (milnacipran) / AbbVie, Pierre Fabre
Enrollment open, HEOR: The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients (clinicaltrials.gov) - Oct 2, 2011
P4, N=50, Recruiting, Sponsor: Emmanuel Katsaros
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| Afrezza (recombinant human insulin inhalation) / MannKind
New P3 trial, Combination therapy: Clinical Trial Evaluating Technosphere (clinicaltrials.gov) - Oct 2, 2011
P3, N=518, Completed, Sponsor: Mannkind Corporation
- | TNF-? kinoid / Neovacs, Debiopharm
Enrollment closed: Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa Antagonists (clinicaltrials.gov) - Oct 2, 2011
P2, N=40, Active, not recruiting, Sponsor: Neovacs
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||| Trial completion, HEOR: A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment (clinicaltrials.gov) - Sep 29, 2011
P=N/A, N=600, Completed, Sponsor: EMD Serono
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||||||||| Nplate (romiplostim) / Amgen, Kyowa Kirin
New P3 trial: Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients (clinicaltrials.gov) - Sep 28, 2011
P3, N=60, Recruiting, Sponsor: Amgen